Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 4
2005 3
2006 1
2007 5
2008 11
2009 6
2010 16
2011 13
2012 21
2013 20
2014 21
2015 23
2016 28
2017 21
2018 15
2019 25
2020 45
2021 70
2022 42
2023 52
2024 30

Text availability

Article attribute

Article type

Publication date

Search Results

401 results

Results by year

Filters applied: . Clear all
Page 1
Iron biology.
Del Vecchio L, Girelli D, Vinchi F, Cozzolino M, Elliott S, Mark PB, Valenti L, Qian C, Guo Q, Qian ZM, Ciceri P, Locatelli F. Del Vecchio L, et al. Among authors: valenti l. Nephrol Dial Transplant. 2024 Apr 24:gfae095. doi: 10.1093/ndt/gfae095. Online ahead of print. Nephrol Dial Transplant. 2024. PMID: 38658189
Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population.
De Vincentis A, Tavaglione F, Namba S, Kanai M, Okada Y, Kamatani Y, Maurotti S, Pedone C, Antonelli Incalzi R, Valenti L, Romeo S, Vespasiani-Gentilucci U. De Vincentis A, et al. Among authors: valenti l. Aliment Pharmacol Ther. 2024 Jun;59(11):1402-1412. doi: 10.1111/apt.17953. Epub 2024 Mar 18. Aliment Pharmacol Ther. 2024. PMID: 38497224
Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver disease.
Marchetti A, Pelusi S, Marella A, Malvestiti F, Ricchiuti A, Ronzoni L, Lionetti M, Moretti V, Bugianesi E, Miele L, Vespasiani-Gentilucci U, Dongiovanni P, Federico A, Soardo G, D'Ambrosio R, McCain MV, Reeves HL, La Mura V, Prati D, Bolli N, Valenti L; EPIDEMIC Study Investigators. Marchetti A, et al. Among authors: valenti l. Hepatology. 2024 Mar 11. doi: 10.1097/HEP.0000000000000839. Online ahead of print. Hepatology. 2024. PMID: 38470216
Hepatic and adipose tissue transcriptome analysis highlights a commonly deregulated autophagic pathway in severe MASLD.
Meroni M, De Caro E, Chiappori F, Longo M, Paolini E, Mosca E, Merelli I, Lombardi R, Badiali S, Maggioni M, Orro A, Mezzelani A, Valenti L, Fracanzani AL, Dongiovanni P. Meroni M, et al. Among authors: valenti l. Obesity (Silver Spring). 2024 May;32(5):923-937. doi: 10.1002/oby.23996. Epub 2024 Mar 4. Obesity (Silver Spring). 2024. PMID: 38439203
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information.
McTeer M, Applegate D, Mesenbrink P, Ratziu V, Schattenberg JM, Bugianesi E, Geier A, Romero Gomez M, Dufour JF, Ekstedt M, Francque S, Yki-Jarvinen H, Allison M, Valenti L, Miele L, Pavlides M, Cobbold J, Papatheodoridis G, Holleboom AG, Tiniakos D, Brass C, Anstee QM, Missier P; LITMUS Consortium investigators. McTeer M, et al. Among authors: valenti l. PLoS One. 2024 Feb 29;19(2):e0299487. doi: 10.1371/journal.pone.0299487. eCollection 2024. PLoS One. 2024. PMID: 38421999 Free PMC article.
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease.
Romeo S, Jamialahmadi O, De Vincentis A, Tavaglione F, Malvestiti F, Li-Gao R, Mancina R, Alvarez M, Gelev K, Maurotti S, Vespasiani-Gentilucci U, Rosendaal F, Kozlitina J, Pajukanta P, Pattou F, Valenti L. Romeo S, et al. Among authors: valenti l. Res Sq [Preprint]. 2024 Feb 6:rs.3.rs-3878807. doi: 10.21203/rs.3.rs-3878807/v1. Res Sq. 2024. PMID: 38405802 Free PMC article. Preprint.
401 results